Dec. 14, 2021 — Robert M. Califf, MD, plans to take a close look at federal policies on generic drugs. He said he recently has served on a committee of the National Academy of Medicine that is examining supply chain issues.
This committee will soon release a report with specific recommendations, Califf said.
“We don’t have enough competitive entities in what’s become sort of a commodity business” of drug manufacturing, Califf said. “So we need a number of steps to make the system more resilient.”